Screener
NeoGenomics NEO Reportable Segment — Other Cost of Operating Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:OtherCostOfOperatingRevenue.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Amortization | 7,634 | 8,124 | 15,267 | 16,486 |
| Depreciation | 8,577 | 9,141 | 17,357 | 18,507 |
| Stock-based compensation | 8,216 | 12,215 | 17,852 | 22,969 |
| Other cost of revenue(1) | 101,831 | 95,525 | 199,715 | 181,342 |
| Other general and administrative(1) | 48,569 | 52,836 | 97,614 | 103,585 |
| Other research and development(1) | 9,934 | 7,859 | 18,393 | 16,961 |
| Other sales and marketing(1) | 26,666 | 23,217 | 50,142 | 44,927 |
| Impairment charges | — | 20,041 | — | 20,041 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's reportable segment — other cost of operating revenue?
- NeoGenomics (NEO) reported reportable segment — other cost of operating revenue of $101.83M in Q2 2026.
- How has NeoGenomics's reportable segment — other cost of operating revenue changed year-over-year?
- NeoGenomics's reportable segment — other cost of operating revenue increased by 6.6% year-over-year, from $95.53M to $101.83M.
- What is the long-term trend for NeoGenomics's reportable segment — other cost of operating revenue?
- Over 3 years (2022 to 2025), NeoGenomics's reportable segment — other cost of operating revenue has grown at a 9.8% compound annual growth rate (CAGR), from $287.01M to $379.54M.
- What does reportable segment — other cost of operating revenue mean?
- Includes direct costs associated with providing services, such as laboratory supplies, personnel costs, and logistics, excluding depreciation and amortization. It is a key indicator of the segment's direct operational efficiency and gross margin health.
Ask your AI about NeoGenomics's reportable segment — other cost of operating revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude